Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barbui

Showing results (341-350 of 380) with videos related to

Pageof 38
Sort By:
Bone Marrow Transplantation|October 29, 2008
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimenM Magni, M Di Nicola, C Carlo-Stella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphomaJ M Foran, A Z Rohatiner, B Coiffier, et al.
Pediatric Transplantation|March 21, 2012
The impact of perioperative transfusion of blood products on survival after pediatric liver transplantationM Nacoti, S Cazzaniga, F Lorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)S Cortelazzo, A Rossi, F Roggero, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, A Rambaldi, et al.
British Journal of Haematology|September 1, 2001
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphomaS Cortelazzo, A Rambaldi, A Rossi, et al.
Leukemia|March 2, 2017
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosisC N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Leukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.
Haematologica|September 1, 1996
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphomaT Lerede, R Bassan, A Rossi, et al.
Leukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.
Pageof 38

Showing results (341-350 of 380) with videos related to

Sort By:
Pageof 38
Bone Marrow Transplantation|October 29, 2008
High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimenM Magni, M Di Nicola, C Carlo-Stella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphomaJ M Foran, A Z Rohatiner, B Coiffier, et al.
Pediatric Transplantation|March 21, 2012
The impact of perioperative transfusion of blood products on survival after pediatric liver transplantationM Nacoti, S Cazzaniga, F Lorusso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
Stage-modified international prognostic index effectively predicts clinical outcome of localized primary gastric diffuse large B-cell lymphoma. International Extranodal Lymphoma Study Group (IELSG)S Cortelazzo, A Rossi, F Roggero, et al.
Advances in Experimental Medicine and Biology|September 29, 1999
Clinical sensitivity to anthracyclines in PH/BCR+ acute lymphoblastic leukemiaR Bassan, A Z Rohatiner, A Rambaldi, et al.
British Journal of Haematology|September 1, 2001
Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphomaS Cortelazzo, A Rambaldi, A Rossi, et al.
Leukemia|March 2, 2017
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosisC N Harrison, A M Vannucchi, J-J Kiladjian, et al.
Leukemia|January 26, 2007
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working groupG Barosi, C Besses, G Birgegard, et al.
Haematologica|September 1, 1996
Therapeutic impact of adult-type acute lymphoblastic leukemia regimens in B-cell/L3 acute leukemia and advanced-stage Burkitt's lymphomaT Lerede, R Bassan, A Rossi, et al.
Leukemia & Lymphoma|May 1, 1996
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemiaA Rambaldi, V Attuati, R Bassan, et al.
Pageof 38